张小江;张辉;杨启文;王瑶;王贺;孙宏莉;刘文静;张丽;赵颖;刘亚丽;郭莉娜;窦红涛;肖盟;徐英春;
ZHANG Xiao-jiang;ZHANG Hui;YANG Qi-wen;WANG Yao;WANG He;SUN Hong-li;LIU Wen-jing;ZHANG Li;ZHAO Ying;LIU Ya-li;GUO Li-na;DOU Hong-tao;XIAO Meng;XU Ying-chun;Department of Clinical Laboratory,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院检验科

摘要(Abstract)：

目的了解世界卫生组织关注的临床重要细菌在北京协和医院的耐药变迁趋势。方法回顾性分析北京协和医院2007年1月1日至2016年12月31日10年间临床分离的46 168株非重复细菌,采用纸片扩散法或自动化仪器法进行药敏试验,按美国临床实验室标准化协会2016年版标准判读药敏结果,采用WHONET 5.6软件进行数据分析。结果46 168株非重复细菌中,铜绿假单胞菌6679株,鲍曼不动杆菌6422株,肠杆菌科细菌24 001株(其中大肠埃希菌11 046株、肺炎克雷伯菌6034株),屎肠球菌2358株,金黄色葡萄球菌6056株,肺炎链球菌652株。10年来,北京协和医院碳青霉烯类耐药铜绿假单胞菌的检出率从38.3%(2007年)下降至22.4%(2016年);碳青霉烯类耐药鲍曼不动杆菌的检出率从52.8%(2007年)上升至71.9%(2016年);碳青霉烯类耐药肠杆菌科的检出率从1.9%(2007年)上升至5.3%(2016年),其中肺炎克雷伯菌对亚胺培南的耐药率从1.3%(2007年)上升至14.4%(2016年);耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)的检出率从56.5%(2007年)下降至27.0%(2016年);屎肠球菌对万古霉素的耐药率近5年为3.3%~5.8%;肺炎链球菌对青霉素不敏感株的检出率近2年为0.9%~6.4%。结论肺炎克雷伯菌和鲍曼不动杆菌对碳青霉烯类的耐药率仍呈上升趋势,给临床的抗感染治疗带来了极大挑战。
Objective This study was to investigate the antibiotic resistance profile of clinically important bacteria that World Health Organization(WHO) is concerned about,in Peking Union Medical College Hospital(PUMCH) from January 1,2007 to December 31,2016. Methods Disc diffusion test(Kirby-Bauer method)and automated systems were employed to detect antibiotic resistance. Data were analyzed by WHONET 5. 6 software according to the 2016 edition of antbioticl susceptibility testing standards issued by the Clinical and Laboratory Standards Institute(CLSI) of the United States. Results A total of 46 168 non-duplicated main clinical i-solates were collected in PUMCH from 2007 to 2016,including 6679 strains of Pseudomonas aeruginosa,6422 strains of Acinetobacter baumannii,24 001 strains of Enterobacteriaceae(11 046 strains of Escherichia coli and6034 strains of Klebsiella pneumonia),2358 strains of Enterococcus faecium,6056 strains of Staphylococcus aureus,652 strains of Streptococcus pneumonia,and 999 strains of Haemophilus influenza. Based on the surveillance data during the 10 years,we found that,the detection rate of the carbapenem-resistant P. aeruginosa decreased from 38. 3% in 2007 to 22. 4% in 2016; the detection rate of carbapenem-resistant A. baumannii increased from 52. 8% in 2007 to 71. 9% in 2016; the imipenem-resistance rate of K. pneumonia increased from1. 3% in 2007 to 14. 4% in 2016. The vancomycin-resistance rate of E. faecium was 3. 3%-5. 8% in recent 5 years. The detection rate of Methicillin-resistant S. aureus(MRSA) decreased from 56. 5% in 2007 to 27. 0%in 2016. The detection rate of penicillin-insensitive S. pneumonia was 0. 9%-6. 4% in recent 2 years. Conclusions The prevalence of carbapenem-resistant K. pneumoniae and A. baumannii is still increasing. Carbapenem-resistant strains pose a huge challenge for anti-infection therapy.

关键词(KeyWords)： 细菌耐药性变迁;抗菌药物;药敏试验
bacterial resistance changes;antimicrobial agents;antimicrobial susceptibility testing

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 张小江;张辉;杨启文;王瑶;王贺;孙宏莉;刘文静;张丽;赵颖;刘亚丽;郭莉娜;窦红涛;肖盟;徐英春;
ZHANG Xiao-jiang;ZHANG Hui;YANG Qi-wen;WANG Yao;WANG He;SUN Hong-li;LIU Wen-jing;ZHANG Li;ZHAO Ying;LIU Ya-li;GUO Li-na;DOU Hong-tao;XIAO Meng;XU Ying-chun;Department of Clinical Laboratory,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College;

Email:

DOI:

参考文献(References)：

• [1]Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing.M100-S26[S].Wayne,PA:CLSI,2016.
• [2]Cuzon G,Ouanich J,Gondret R,et al.Outbreak of OXA-48-postive carbapenem-resistant Klebsiella pneumonia isolates in France[J].Antimicrob Agents Chemother,2011,55:2420-2423.
• [3]胡付品,郭燕,朱德妹,等.2016年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2017,17:481-491.
• [4]国家卫生和计划生育委员会.中国抗菌药物管理和细菌耐药现状报告[M].北京:中国协和医科大学出版社,2017:35-36,41.
• [5]Liu Y,Li XY,Wan LG,et al.Molecular characterization of the bla(KPC-2)gene in clinical isolates of carbapenemresistant Klebsiella pneumonia from the pediatric wards of a Chinese hospital[J].J Microbiol,2012,58:1167-1173.
• [6]European Centre for Disease Prevention and Control.Annual epidemiological report.Antimicrobial resistance and healthcare-associated infections,2014[R].Stockholm:ECDC,2014.
• [7]Hu F,Chen S,Xu X,et al.Emergence of carbapenem-resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai,China[J].J Med Microbiol,2012,61:132-136.
• [8]Chen S,Hu F,Liu Y,et al.Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China[J].Am J Infect Control,2011,39:e55-e60.
• [9]Zhu J,Ding B,Xu X,et al.Klebsiella pneumoniae:development of carbapenem resistance due to acquisition of bla NDM-1 during antimicrobial therapy in twin infants with pneumonia[J].Front Microbiol,2015,6:1399.
• [10]王明贵.广泛耐药革兰阴性菌感染的实验诊断、抗菌治疗及医院感染控制:中国专家共识[J].中国感染与化疗杂志,2017,17:82-92.
• [11]张辉,张小江,徐英春,等.2005-2014年CHINET不动杆菌属细菌耐药性监测[J].中国感染与化疗杂志,2016,16:429-436.
• [12]杨青,俞云松,林洁,等.2005-2014年CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2016,16:146-152.
• [13]张祎博,孙景勇,倪语星,等.2005-2014年CHINET铜绿假单胞菌耐药性监测[J].中国感染与化疗杂志,2016,16:141-145.
• [14]Etrosillo N,Giannella M,Lewis R,et al.Treatment of carbapenem-resistant Klebsiella pneumoniae:the state of the art[J].Expert Rev Anti Infect Ther,2013,11:159-177.
• [15]Temkin E,Adler A,Lemer A,et al.Carbapenem-resistant Enterobacteriaceae:biology,epidemiology,and management[J].Ann N Y Acad Sci,2014,1323:22-42.
• [16]Abbaz RF,Moseley RR,Steiner RJ,et al.Challenges of infectious diseases in the USA[J].Lancet,2014,384:53-63.